HIGHLIGHTS
- who: TRPV et al. from the Jiangmen Central Hospital, China University of Alabama at Birmingham have published the paper: Transient receptor potential vanilloid type 4 (TRPV4) promotes tumorigenesis via NFAT4 activation in nasopharyngeal carcinoma, in the Journal: (JOURNAL)
- what: The study demonstrates for the first time that TRPV4 promotes NPC cell growth via the Ca 2+ /calcineurin/NFAT4 axis, and highlights the therapeutic potential of targeting the TRPV4/ Ca 2+ /calcineurin/NFAT4 signaling pathway.
SUMMARY
TRPV4 links calcium signaling to DDX3X activity, which is essential for cancer-associated EBV infections (Donate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.